23325603|t|Effects of edaravone on amyloid-beta precursor protein processing in SY5Y-APP695 cells.
23325603|a|Previous reports have revealed that reactive oxygen species (ROS) is involved in the development of Alzheimer's disease (AD), and recent studies indicate that free radical-generating systems can regulate amyloid-beta precursor protein (APP) processing. Edaravone is a novel free radical scavenger currently used to reduce cerebral damages after acute cerebral infarction. In the present study, we used SH-SY5Y cells stably transfected with the human "Swedish" APP mutation APP695 (SY5Y-APP695swe) as an in vitro model to investigate the effect of edaravone on APP processing. The result showed that edaravone treatment for 24 h down-regulated beta-amyloid (Abeta) production in a dose-dependent manner. Moreover, edaravone modulated APP processing by increasing alpha-secretase-derived APP fragments and decreasing beta-secretase-derived APP fragments. In addition, the mRNA and protein levels of insulin degrading enzyme (IDE) and neprilysin (NEP), two key Abeta degrading enzymes, were not changed after edaravone administration. Taken together, our data suggested that edaravone played an important role in regulating Abeta production by enhancing the non-amyloidogenic pathway and inhibiting the amyloidogenic pathway. Thus, edaravone may be potentially useful for treating Alzheimer's disease (AD). 
23325603	11	20	edaravone	Chemical	MESH:D000077553
23325603	24	54	amyloid-beta precursor protein	Gene	351
23325603	69	80	SY5Y-APP695	CellLine	CVCL:0019
23325603	124	147	reactive oxygen species	Chemical	MESH:D017382
23325603	149	152	ROS	Chemical	MESH:D017382
23325603	188	207	Alzheimer's disease	Disease	MESH:D000544
23325603	209	211	AD	Disease	MESH:D000544
23325603	247	259	free radical	Chemical	MESH:D005609
23325603	292	322	amyloid-beta precursor protein	Gene	351
23325603	341	350	Edaravone	Chemical	MESH:D000077553
23325603	362	374	free radical	Chemical	MESH:D005609
23325603	410	426	cerebral damages	Disease	MESH:D002539
23325603	433	458	acute cerebral infarction	Disease	MESH:D056989
23325603	490	497	SH-SY5Y	CellLine	CVCL:0019
23325603	532	537	human	Species	9606
23325603	569	573	SY5Y	CellLine	CVCL:0019
23325603	635	644	edaravone	Chemical	MESH:D000077553
23325603	687	696	edaravone	Chemical	MESH:D000077553
23325603	745	750	Abeta	Gene	351
23325603	801	810	edaravone	Chemical	MESH:D000077553
23325603	985	1009	insulin degrading enzyme	Gene	3416
23325603	1011	1014	IDE	Gene	3416
23325603	1020	1030	neprilysin	Gene	4311
23325603	1032	1035	NEP	Gene	4311
23325603	1046	1051	Abeta	Gene	351
23325603	1094	1103	edaravone	Chemical	MESH:D000077553
23325603	1160	1169	edaravone	Chemical	MESH:D000077553
23325603	1209	1214	Abeta	Gene	351
23325603	1317	1326	edaravone	Chemical	MESH:D000077553
23325603	1366	1385	Alzheimer's disease	Disease	MESH:D000544
23325603	1387	1389	AD	Disease	MESH:D000544
23325603	Association	351	4311
23325603	Negative_Correlation	MESH:D000077553	MESH:D056989
23325603	Association	MESH:D017382	MESH:D000544
23325603	Negative_Correlation	MESH:D000077553	351
23325603	Negative_Correlation	MESH:D000077553	MESH:D002539
23325603	Negative_Correlation	MESH:D000077553	MESH:D000544
23325603	Negative_Correlation	MESH:D000077553	MESH:D005609
23325603	Association	3416	351

